News
LLY's non-obesity drugs like Verzenio and Taltz are fueling sales growth as investor focus stays on GLP-1 blockbusters.
5d
Zacks Investment Research on MSNNVO vs. LLY: Which Obesity Powerhouse is the Stronger Bet Now?Novo Nordisk NVO and Eli Lilly LLY dominate the diabetes and obesity market on the back of the tremendous success of their ...
California legislators have pulled Medicaid coverage for pricey weight loss drugs like Zepbound to patch a $12 billion budget ...
LLY's blockbuster obesity drugs fuel rapid growth but ABBV's valuation and pipeline may offer safer short-term upside.
soccer Hingham’s Lilly Reale named to national women’s soccer team training camp roster By Emma Healy Globe Staff,Updated June 18, 2025, 2:31 p.m.
Eli Lilly offered a 115% premium for Verve, signaling a major vote of confidence in gene editing platforms. HC Wainwright and William Blair downgraded Verve after the deal. Market-moving news hits ...
"I don't need a megaphone courtside. I'm that loud": How Lilly Singh became the Toronto Tempo's chief hype officer - Toronto Life 15 15 City News ...
Aubrey Anderson-Emmons, who is popular for playing the character of Lily in the sitcom Modern Family, has come out as bisexual. She shared the news on social media and used one of Lily's iconic ...
Boston Globe via Getty Images Eli Lilly’s $1.3 billion acquisition of Verve Therapeutics represents a strategic move into cardiovascular genetic medicine.
Eli Lilly (LLY -2.40%) has been one of the hottest healthcare stocks to own in recent years, thanks in large part to the success of its incredibly successful GLP-1 agonist drugs, which help ...
Tate McRae’s makeup artist, Lilly Keys, shares the secrets behind the singer’s looks, and reveals her favorite products and how she gets red-carpet ready.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results